Allogeneic cell therapy hasn’t caught up to autologous cell therapy yet, and the disappointing data so far has soured the entire allogeneic field for at least one venture capitalist. The cell therapy debate was one of the topics covered during a panel discussion at the Biopharm America conference.
The contract research organization's announcement came as clinical trial sites anticipate significant disruption due to the pandemic, while the FDA has issued guidelines for running trials virtually.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Through the funding round, which was led by Dioko Ventures, the health tech startup, Feedtrail, intends to hire sales and marketing employees and scale its platform.
About 78 percent of survey participants achieved positive ROI from mobile app investments, according to the survey by open source software developer Red Hat.
Instead of a per user, per month fee that rival companies tend to charge, MD Interconnect charges a flat fee and annual maintenance fee roughly correlated to the size of the hospital.
Healthcare dignity for sale.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Valencell, a biosensor developer seeking to make weareables more accurate, has raised a mix of equity and debt. The fundraise comes several months after securing approval for patent applications earlier this year.
Pending FDA approval, women could soon have their own drug designed to increase sexual desire.
If there’s a counter argument for that University of Pennsylvania study suggesting there’s little difference between the accuracy of smartphone fitness apps and fitness wearables to track steps, Steve LeBoeuf would be the one to make it. He’s the president of Valencell, a company that develops and licenses its PerformTech technology that powers several wearable […]
A health IT company that has developed a cloud-based logistics tool to delivery physicians to patients' homes is raising $1.75 million.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A portable device for ambulances could someday soon make it easier and quicker for emergency responders to treat cardiac arrest and stroke victims with therapeutic hypothermia. Novocor Medical Systems Inc. is developing HypoCore, a device that’s designed to quickly cool saline as it’s administered to patients to induce therapeutic hypothermia. In cardiac arrest patients, therapeutic […]
Sprout Pharmaceuticals’ quest to get approval for what would be the first drug to treat sexual dysfunction in premenopausal women made a big step today. It has resubmitted its NDA to the U.S. Food and Drug Administration, according to a statement, resetting the path for the drug when it was under development at Boehringer Ingelheim. […]
"It means I get three more, really good meals," said Heath, 29, of Wake Forest, N.C. "The foo...
A team at North Carolina State University’s College of Textiles is asking patients to help them solve a long-standing problem: embarrassing hospital gowns. Anyone who has been a hospital patient knows the uneasy, drafty feeling the unisex garment that “ties” loosely in the back. The “johnny gown” endures largely because it fulfills the hospital need […]
With its cancer products portfolio nearing a launch, DARA BioSciences (NASDAQ:DARA) is making the adjustments necessary to transition to become a revenue-producing company. DARA earlier this month closed on a stock sale that raised just over $10 million to support commercialization of its cancer products. Now the company is making some management moves to prepare […]